Sort
15,440 grants matching “organoids”
Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders
$358,179Cynthia Tifft · National Human Genome Research Institute · ZIA · FY2022 · HG
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
$358,102Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2016 · CA
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$358,047Richard B Silverman · Northwestern University · R01 · FY2022 · CA
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis
$358,011Lanlan Shen · Baylor College Of Medicine · R01 · FY2019 · CA
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis
$358,011Lanlan Shen · Baylor College Of Medicine · R01 · FY2020 · CA
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis
$358,011Lanlan Shen · Baylor College Of Medicine · R01 · FY2021 · CA
PKD1 signaling in the initiation of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2016 · CA
Activation of TGFb signaling using novel SMAD4 molecular glues
$357,994Xiulei Mo · Emory University · R37 · FY2024 · CA
PKD1 signaling in the initiation of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2017 · CA
PKD1 signaling in the initiation of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Robust-to-fragile transitions of a phase-separated mitotic organelle in triple-negative breast cancer
$357,982P. Todd Stukenberg · University Of Virginia · U54 · FY2023 · CA
Guanylin GUCY2C axis in Colorectal Cancer Initiation
$357,970Scott A. Waldman · Thomas Jefferson University · R01 · FY2020 · CA
Guanylin GUCY2C axis in Colorectal Cancer Initiation
$357,970Scott A. Waldman · Thomas Jefferson University · R01 · FY2021 · CA
Epigenomic control of antimicrobial immunity in the intestine
$357,887Theresa Alenghat · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Epigenomic control of antimicrobial immunity in the intestine
$357,884Theresa Alenghat · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Epigenomic control of antimicrobial immunity in the intestine
$357,880Theresa Alenghat · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
CANCAN - SALK
$357,827Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2023 · CA
Impact of CREB-driven mechanism in shaping the tumor-immune landscape
$357,796Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R01 · FY2025 · CA
Preclinical characterization of saracatinib for cystic fibrosis therapy
$357,751Anil Jegga · Cincinnati Childrens Hosp Med Ctr · UH3 · FY2020 · TR
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2022 · DK
Host integration of commensal and pathogenic bacterial-derived signals
$357,750Theresa Alenghat · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2020 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2021 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2023 · DK
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2021 · DK